These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2231868)

  • 1. Chronopharmacokinetics of theophylline in the cat.
    Dye JA; McKiernan BC; Neff-Davis CA; Koritz GD
    J Vet Pharmacol Ther; 1990 Sep; 13(3):278-86. PubMed ID: 2231868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained-release theophylline pharmacokinetics in the cat.
    Dye JA; McKiernan BC; Jones SD; Neff-Davis CA; Koritz GD
    J Vet Pharmacol Ther; 1989 Jun; 12(2):133-40. PubMed ID: 2746720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of four slow-release theophylline formulations in the beagle dog.
    Koritz GD; McKiernan BC; Neff-Davis CA; Munsiff IJ
    J Vet Pharmacol Ther; 1986 Sep; 9(3):293-302. PubMed ID: 3761420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
    Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
    Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of an extended-release theophylline product in cats.
    Guenther-Yenke CL; McKiernan BC; Papich MG; Powell E
    J Am Vet Med Assoc; 2007 Sep; 231(6):900-6. PubMed ID: 17867974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
    Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
    Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent inconsistent theophylline absorption from sustained release capsules.
    Uden DL; Schaber DE; Wyatt RA
    Clin Pediatr (Phila); 1987 Jun; 26(6):285-7. PubMed ID: 3581636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose comparison of three slow-release theophylline oral preparations in healthy Thai volunteers.
    Kanthawatana S; Tontayapiwat A; Tonsuwannont W; Manorot M
    Asian Pac J Allergy Immunol; 1996 Jun; 14(1):13-8. PubMed ID: 8980795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rise and fall of serum theophylline concentration: a comparison of sustained-release formulations in volunteers with rapid theophylline clearance.
    Mucklow JC; Kuhn S
    Br J Clin Pharmacol; 1985 Dec; 20(6):589-96. PubMed ID: 4091990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma.
    Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Harris JB
    Ther Drug Monit; 1988; 10(4):395-400. PubMed ID: 3059587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
    Goetz TE; Munsiff IJ; McKiernan BC
    J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of enteral feedings on sustained-release theophylline absorption.
    Plezia PM; Thornley SM; Kramer TH; Armstrong EP
    Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.
    Hurwitz A; Karim A; Burns TS
    J Clin Pharmacol; 1987 Nov; 27(11):855-61. PubMed ID: 3429692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
    Stein GE; Haughey DB; Ross RJ; Vakoutis J
    Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline-terbutaline, a steady state study on possible pharmacokinetic interactions with special reference to chronopharmacokinetic aspects.
    Jonkman JH; Borgström L; van der Boon WJ; de Noord OE
    Br J Clin Pharmacol; 1988 Sep; 26(3):285-93. PubMed ID: 3179168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
    Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
    Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.